Zur Kurzanzeige

Die Auswirkungen des selektiven Androgenrezeptor-Modulators Enobosarm auf die Skelettmuskulatur der orchiektomierten Ratte

dc.contributor.advisorBrück, Wolfgang Prof. Dr.
dc.contributor.authorWolgast, Johannes Valentin Boy Billy-Rubin
dc.date.accessioned2020-03-23T11:56:33Z
dc.date.available2020-12-31T23:50:02Z
dc.date.issued2020-03-23
dc.identifier.urihttp://hdl.handle.net/21.11130/00-1735-0000-0005-136C-D
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-7924
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-7924
dc.language.isodeude
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610de
dc.titleDie Auswirkungen des selektiven Androgenrezeptor-Modulators Enobosarm auf die Skelettmuskulatur der orchiektomierten Rattede
dc.typedoctoralThesisde
dc.title.translatedThe effects of the selective androgen receptor modulator Enobosarm on the skeletal muscle of the orchiectomized ratde
dc.contributor.refereeSehmisch, Stephan Prof. Dr.
dc.date.examination2020-04-22
dc.description.abstractengOsteoporosis and sarcopenia are closely related diseases, which together affect our musculoskeletal system. Long researched as female diseases, the potential therapeutic effects of the selective androgen receptor modulator (SARMs) Enobosarm on the musculoskeletal system were now investigated using the osteoporotic model of the orchiectomized rat. This thesis deals exclusively with research on skeletal muscles. The experiment commenced with bilateral orchiectomy. After twelve weeks, all experimental animals underwent bilateral femoral osteotomy followed by stable plate osteosynthesis. After an additional six weeks, the animals were finally sacrificed to science. At the beginning of the experiment, 90 animals were divided into six groups: 1. (nonORX): non-orchiectomized; 2. (ORX): orchiectomized; 3. (SARMT): orchiectomized + Enobosarm, 0.4 mg/kg BW/d p.o., for the last six weeks; 4. (SARMP): orchiectomized + Enobosarm, 0.4 mg/kg BW/d p.o., for 18 weeks; 5. (TestT): orchiectomized + testosterone propionate, 46.67 mg/kg BW/d p.o., for the last six weeks; 6. (TestT): orchiectomized + testosterone propionate, 46.67 mg/kg BW/d p.o., for 18 weeks. The body weights of the test animals and the quantities of food consumed were recorded weekly. The Mm. longissimi, gastrocnemii and solei were histologically prepared post mortem and microscopically evaluated. The ratio of type 1 to type 2 muscle cells, the muscle cell cross-sectional surfaces and equatorial diameters as well as the capillary density were determined. The activity of creatine kinase in serum, the muscle weights, including M. levator ani, and prostate weights were also determined. Short-term treatment with Enobosarm and testosterone propionate (SARMT, TestT) tended to have beneficial effects on the skeletal muscles of the orchiectomized rat without significantly increasing the weight of the prostate. On the other hand, long-term therapy with Enobosarm (SARMP) led to increased prostate weights and did not have a clearly beneficial effect on skeletal muscles. For long-term applicability of Enobosarm, the application of lower doses should be investigated. Furthermore, a synergistic effect of substance and muscular training would be conceivable and should also be considered in the future.de
dc.contributor.coRefereevon Haehling, Stephan Prof. Dr.
dc.contributor.thirdRefereeSchön, Margarete Prof. Dr.
dc.subject.gerSARMde
dc.subject.gerOrchiektomiede
dc.subject.gerRattede
dc.subject.gerEnobosarmde
dc.subject.gerMuskelde
dc.subject.engSARMde
dc.subject.engratde
dc.subject.engmusclede
dc.subject.engEnobosarmde
dc.subject.engorchiectomyde
dc.identifier.urnurn:nbn:de:gbv:7-21.11130/00-1735-0000-0005-136C-D-0
dc.affiliation.instituteMedizinische Fakultätde
dc.subject.gokfullGOK-MEDIZINde
dc.subject.gokfullRehabilitation / Physiotherapie / Krankengymnastik / Massage - Allgemein- und Gesamtdarstellungen (PPN619876565)de
dc.subject.gokfullOrthopädie (PPN619876204)de
dc.subject.gokfullChirurgie - Allgemein- und Gesamtdarstellungen (PPN619875968)de
dc.subject.gokfullInnere Medizin - Allgemein- und Gesamtdarstellungen (PPN619875747)de
dc.description.embargoed2020-12-31
dc.identifier.ppn1693163020


Dateien

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige